Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multiplatform molecular test performance in indeterminate thyroid nodules.

Diagnostic cytopathology - 1 Dec 2020

Lupo Mark A, Walts Ann E, Sistrunk J Woody, Giordano Thomas J, Sadow Peter M, Massoll Nicole, Campbell Ryan, Jackson Sara A, Toney Nicole, Narick Christina M, Kumar Gyanendra, Mireskandari Alidad, Finkelstein Sydney D, Bose Shikha

Abstract excerpt

BACKGROUND: Approximately 25% of thyroid nodule fine-needle aspirates (FNAs) have cytology that is indeterminate for malignant disease. Accurate risk stratification of these FNAs with ancillary testing would reduce unnecessary thyroid surgery. METHODS: We evaluated the performance of an ancillary multiplatform test (MPTX) that has three diagnostic categories (negative, moderate, and positive). MPTX includes the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Biopsy, Fine-Needle

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MicroRNAs

Share to Predictive Value of Tests

Share to Sensitivity and Specificity

Share to Thyroid Gland

Share to Thyroid Neoplasms

Share to Thyroid Nodule

Source

Open in PubMed Open full text

Identifiers

PMID: 32767735
DOI: 10.1002/dc.24564
PMCID: PMC7754490

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multiplatform molecular test performance in indeterminate thyroid nodules.PMID 32767735Read ↗

Clinical performance of multiplatform mutation panel and microRNA risk classifier in indeterminate thyroid nodules.Semantic proximity Read ↗

Evaluating the clinical performance of an updated microRNA classifier in indeterminate and RAS-mutated thyroid nodule management: A multi-institutional study.Semantic proximity Read ↗

Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: A multi-institutional study.Semantic proximity Read ↗

The actual and future role of molecular tests in thyroid pathology.Semantic proximity Read ↗

How genetics changed or will change the therapy in thyroid nodules with indeterminate cytology?Semantic proximity Read ↗

Molecular Testing for Indeterminate Thyroid Nodules: Association of Negative Predictive Value With Nodule Size.Semantic proximity Read ↗

A Retrospective Evaluation of the Diagnostic Performance of an Interdependent Pairwise MicroRNA Expression Analysis with a Mutation Panel in Indeterminate Thyroid Nodules.Semantic proximity Read ↗

Risk stratification of indeterminate thyroid nodules by novel multigene testing: a study of Asians with a high risk of malignancy.Semantic proximity Read ↗

Diagnostic potential of ancillary molecular testing in differentiation of benign and malignant thyroid nodules.Semantic proximity Read ↗

Incremental utility of expanded mutation panel when used in combination with microRNA classification in indeterminate thyroid nodulesSemantic proximity Read ↗

Diagnostic and prognostic value of a 7-panel mutation testing in thyroid nodules with indeterminate cytology: the SWEETMAC study.Semantic proximity Read ↗

Clinical use of Molecular Data in Thyroid Nodules and CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.